Literature DB >> 31876406

Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Pengfei Fu1, Meng Gao2, Ken Kin Lam Yung1.   

Abstract

Parkinson's disease (PD) and Alzheimer's disease (AD) are the most common neurodegenerative disorders, with an overall global incidence of 40 million. Many studies have revealed the association of intestinal disorders and bacterial infections with PD, but few studies have found such a relationship with AD. In this meta-analysis, related articles published up to September 2018 were searched in PubMed. Of the 2121 related articles screened initially, 56 were found to be eligible. Data on the risks of PD and AD due to five intestinal disorders and infection with Helicobacter pylori, as a representative intestinal microbe, were obtained, and a fixed- or random-effects model was used to pool the odds ratios (ORs) with 95% confidence interval (CIs) from individual studies. The combined OR for all types of intestinal disorders with an increased risk of PD was 3.36 (95% CI: 2.70-4.17). The ORs for each category were as follows: constipation, 4.05 (95% CI, 3.24-5.06); inflammatory bowel disease (IBD), 1.16 (95% CI, 0.89-1.52); irritable bowel syndrome (IBS), 1.75 (95% CI, 0.55-5.56); small intestinal bacterial overgrowth, 5.15 (95% CI, 3.33-7.96); and diarrhea, 1.27 (95% CI, 0.28-5.75). The combined OR of all types of intestinal disorders with an increased risk of AD was 1.52 (95% CI, 1.09-2.13). The ORs for IBS and IBD were 1.42 (95% CI, 1.02-1.99) and 2.40 (95% CI, 1.00-5.76), respectively. The risk estimates of H. pylori infection in PD and AD patients were as follows: OR, 1.65 (95% CI, 1.43-1.91) and OR, 1.40 (95% CI, 1.12-1.76), respectively. These findings suggest that PD and AD are significantly associated with intestinal disorders. The negative roles of H. pylori in the development of PD or AD should be evaluated to shed new light on the diagnosis and treatment of PD and AD. National governments should periodically inspect the intestinal condition of residents and extend health plans to improve intestinal health to prevent potential neurological disorders.

Entities:  

Keywords:  Alzheimer’s disease; H. pylori; Intestinal disorders; Parkinson’s disease; meta-analysis

Year:  2020        PMID: 31876406     DOI: 10.1021/acschemneuro.9b00607

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  25 in total

1.  Differences in Alpha Diversity of Gut Microbiota in Neurological Diseases.

Authors:  Zhuoxin Li; Jie Zhou; Hao Liang; Li Ye; Liuyan Lan; Fang Lu; Qing Wang; Ting Lei; Xiping Yang; Ping Cui; Jiegang Huang
Journal:  Front Neurosci       Date:  2022-06-28       Impact factor: 5.152

2.  Exploration of the Common Gene Characteristics and Molecular Mechanism of Parkinson's Disease and Crohn's Disease from Transcriptome Data.

Authors:  Haoran Zheng; Xiaohang Qian; Wotu Tian; Li Cao
Journal:  Brain Sci       Date:  2022-06-13

3.  Non-canonical cholinergic anti-inflammatory pathway in IBD.

Authors:  Alan de Araujo; Guillaume de Lartigue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11       Impact factor: 46.802

Review 4.  Neurodegenerative disorders and gut-brain interactions.

Authors:  Alpana Singh; Ted M Dawson; Subhash Kulkarni
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

5.  The gut microbiota and nervous system: Age-defined and age-defying.

Authors:  Annelise A Madison; Janice K Kiecolt-Glaser
Journal:  Semin Cell Dev Biol       Date:  2021-01-06       Impact factor: 7.499

6.  Predictive Potential of Circulating Ube2h mRNA as an E2 Ubiquitin-Conjugating Enzyme for Diagnosis or Treatment of Alzheimer's Disease.

Authors:  Key-Hwan Lim; Jae-Yeol Joo
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

Review 7.  Helicobacter pylori infection: Beyond gastric manifestations.

Authors:  Maria Luísa Cordeiro Santos; Breno Bittencourt de Brito; Filipe Antônio França da Silva; Mariana Miranda Sampaio; Hanna Santos Marques; Natália Oliveira E Silva; Dulciene Maria de Magalhães Queiroz; Fabrício Freire de Melo
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

8.  Acute colitis during chronic experimental traumatic brain injury in mice induces dysautonomia and persistent extraintestinal, systemic, and CNS inflammation with exacerbated neurological deficits.

Authors:  Terez Shea-Donohue; Alan I Faden; Marie Hanscom; David J Loane; Taryn Aubretch; Jenna Leser; Kara Molesworth; Nivedita Hedgekar; Rodney M Ritzel; Gelareh Abulwerdi
Journal:  J Neuroinflammation       Date:  2021-01-18       Impact factor: 8.322

Review 9.  The Impact of Disease Comorbidities in Alzheimer's Disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2021-02-12       Impact factor: 5.750

Review 10.  The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline.

Authors:  Per Borghammer
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.